Aubrey de Lavenu Harold Andre 5
5 · CEN BIOTECH INC · Filed May 28, 2021
Insider Transaction Report
Form 5
CEN BIOTECH INCCENBF
Aubrey de Lavenu Harold Andre
Director
Transactions
- Other
Convertible note
2018-11-15$1.60/sh−171,632$274,611→ 548,980 totalExercise: $1.60From: 2016-11-25→ Common Stock (107,270 underlying)
Footnotes (3)
- [F1]On November 15, 2018, $171,632 of a $200,000 convertible promissory note issued by the issuer on November 25, 2016 to the reporting person was repaid by the issuer to the reporting person thereby reducing the amount due under the note to $28,368 and accordingly reducing the number of common stock shares of the issuer issuable upon conversion of the promissory note from 125,000 shares of common stock by 107,270 shares of common stock to 17,730 shares of common stock.
- [F2]The convertible note matured on November 25, 2018, however, the ability to convert the note into shares did not expire on such maturity date.
- [F3]At December 31, 2018, the reporting person also held 33,321 shares of the issuer's common stock directly, and held convertible promissory notes convertible into 548,980 shares of the issuer's common stock.